Skip to main content
FinSpry Logo
FinSpry
NAMS logo
NAMS
(NASDAQ)
NewAmsterdam Pharma Company N.V.
$32.99-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

NewAmsterdam Pharma Company (NAMS) Stock Price & Financial Analysis

NewAmsterdam Pharma Company Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$31.61 - $33.23
52-Week High$42.00
52-Week Low$14.06
Open$31.65
Volume725.31K
Average Volume (3M)725.31K
Market Cap3.77B
Shares Outstanding114.40M
Price to Sales (P/S)166.80
Price to Book (P/B)5.49
EV/EBITDA-14.48
Revenue (TTM)22.50M
Net Income (TTM)-203.82M
Free Cash Flow (TTM)-148.03M
EPS (TTM)$-1.78
Profit Margin-905.74%
Operating Margin-1002.90%
Return on Equity (ROE)-29.82%
Debt to Equity0.00
50-Day MA$32.38
200-Day MA$30.34
52-Week Change78.51%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About NewAmsterdam Pharma Company

What is the current stock price for NAMS?

As of the latest trading session, NAMS stock trades at $32.99. The 52-week range is $14.06–$42.00, with a day range of $31.61–$33.23.

What is the P/E ratio for NAMS?

The P/E ratio (Price-to-Earnings) for NAMS is shown in the Key Statistics section. This valuation metric helps compare NewAmsterdam Pharma Company N.V. to industry peers.

Does NAMS pay dividends?

NewAmsterdam Pharma Company does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NAMS?

Based on 7 analysts, the consensus for NAMS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of NAMS?

NewAmsterdam Pharma Company's market capitalization is $3.77B, classifying it as a mid-cap company. NewAmsterdam Pharma Company operates in the Healthcare sector within the Biotechnology industry.